Current role
Christopher Downs
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
CNS Pharmaceuticals, Inc. (CNSP)
SEC 8-K
Current2026-03-02–present
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CNS Pharmaceuticals, Inc. (CNSP) | Senior Vice President – Finance, (Former Chief Financial Officer) | $450,000 | $728,809 |
| 2024 | CNS Pharmaceuticals, Inc. (CNSP) | Senior Vice President – Finance, (Former Chief Financial Officer) | $340,000 | $621,050 |
| 2023 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Financial Officer | $340,000 | $401,515 |
| 2022 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Financial Officer | $340,000 | $481,224 |
| 2021 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Financial Officer | $340,000 | $480,475 |
| 2020 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Financial Officer | $300,000 | $790,999 |
| 2019 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Financial Officer | $40,000 | $1,154,115 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.